We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cayman Darglitazone
Product Description
Thiazolidinediones (TZDs) are a group of structurally related peroxisome proliferator-activated receptor γ (PPARγ) agonists with antidiabetic actions in vivo., Darglitazone is a TZD that increases the sensitivity of cells to insulin, stimulating insulin-induced PI3K activity at submicromolar concentrations by increasing the expression of the p85 subunit of PI3K. It increases insulin effectiveness in obese non-insulin-dependent diabetes mellitus subjects. Darglitazone promotes adipocyte differentiation by up-regulating the expression of uncoupling protein-2. Through PPARγ, darglitazone restores acute inflammatory responses to cerebral hypoxia-ischemia and reduces infarct size in diabetic ob/ob mice.
WARNING This product is not for human or veterinary use.
Technical Information
- CP 86,325
- DMF: 20 mg/mL
- DMSO: 20 mg/mL
- Ethanol: 5 mg/mL
Shipping & Storage Information
| SKU | CAYM-17681-1 |
|---|---|
| Supplier Part Number | 17681-1 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| MSDS URL | Click here |
| Temperature | -20 |
| Refrigerated-Frozen | Y |
| CountryOfOrigin | Canada |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | N |
| CAS Number | 141200-24-0 |
| Energy Star | No |
| Green | No |
| Controlled | N |